CPEX Pharmaceuticals, Inc.·4/A

Sep 30, 1:57 PM ET

Hebert Robert P 4/A

4/A · CPEX Pharmaceuticals, Inc. · Filed Sep 30, 2009

Insider Transaction Report

Form 4/AAmended
Period: 2009-09-29
Hebert Robert P
Chief Financial Officer
Transactions
  • Award

    Right to Purchase

    2009-09-29+2,1052,105 total
    Exercise: $10.00Exp: 2019-09-29Common Stock, $0.01 par value (2,105 underlying)
  • Award

    Restricted Stock Units

    2009-09-29+402402 total
    Common Stock, $0.01 par value (402 underlying)
Footnotes (4)
  • [F1]The original report on Form 4 filed on 9/30/2009 is being amended to correct the amount of securities beneficially owned following the reported transaction.
  • [F2]Options were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan. Grant become exercisable in three equal installments on 9/29/2010, 9/29/2011 and 9/29/2012.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of CPEX Pharmaceuticals, Inc. Common Stock, $0.01 par value.
  • [F4]Restricted stock units were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan.Units vest, and will be issued to the reporting person in three equal installments on 9/29/2010, 9/29/2011 and 9/29/2012.

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT